Clinical trial • Phase I • Oncology

Clinical trial in Hepatocellular carcinoma | Advanced or metastatic hepatocellular carcinoma

Phase I trial for Hepatocellular carcinoma | Advanced or metastatic hepatocellular carcinoma. 127 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Hepatocellular carcinoma | Advanced or metastatic hepatocellular carcinoma
Trial Stage
Phase I

Key dates

Initial CTIS Submission Date
28-03-2025
First CTIS Authorization Date
27-06-2025

Trial design

Phase I trial across 3 sites in Italy.

Target Sample Size
127

Recruitment

Planned Sample Size
127
Recruitment Window Months
24

Geography

Total Number Of Sites
3
Total Number Of Participants
127

Italy

Earliest CTIS Part Ii Submission Date
13-06-2025
Latest Decision Or Authorization Date
28-04-2026
Processing Time Days
319
Number Of Sites
3
Number Of Participants
31

Sites

Site Name
Humanitas Mirasole S.p.A.
Department Name
Operative unit of Oncology and Hematology
Principal Investigator Name
Armando Santoro
Contact Person Name
Armando Santoro
Site Name
Ospedale San Raffaele S.r.l.
Department Name
U.O. Oncologia Medica unità di Fase I
Principal Investigator Name
Gianluca Del Conte
Contact Person Name
Gianluca Del Conte
Contact Person Email
delconte.gianluca@hsr.it
Site Name
Centro Ricerche Cliniche Di Verona S.r.l.
Department Name
Oncology Unit
Principal Investigator Name
Michele Milella
Contact Person Name
Michele Milella
Contact Person Email
Michele.milella@univr.it

Sponsor

Primary sponsor

Full Name
Alnylam Pharmaceuticals Inc.
Organisation Type
Pharmaceutical company
Country Of Registered Address
United States

Related trials

Other published trials that may interest you.